These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 28429652)

  • 1. Atypical regulators of Wnt/β-catenin signaling as potential therapeutic targets in Hepatocellular Carcinoma.
    Chen J; Rajasekaran M; Hui KM
    Exp Biol Med (Maywood); 2017 Jun; 242(11):1142-1149. PubMed ID: 28429652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The microtubule-associated protein PRC1 promotes early recurrence of hepatocellular carcinoma in association with the Wnt/β-catenin signalling pathway.
    Chen J; Rajasekaran M; Xia H; Zhang X; Kong SN; Sekar K; Seshachalam VP; Deivasigamani A; Goh BK; Ooi LL; Hong W; Hui KM
    Gut; 2016 Sep; 65(9):1522-34. PubMed ID: 26941395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation.
    Abitbol S; Dahmani R; Coulouarn C; Ragazzon B; Mlecnik B; Senni N; Savall M; Bossard P; Sohier P; Drouet V; Tournier E; Dumont F; Sanson R; Calderaro J; Zucman-Rossi J; Vasseur-Cognet M; Just PA; Terris B; Perret C; Gilgenkrantz H
    J Hepatol; 2018 Jun; 68(6):1203-1213. PubMed ID: 29525529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wnt signaling and hepatocarcinogenesis: molecular targets for the development of innovative anticancer drugs.
    Pez F; Lopez A; Kim M; Wands JR; Caron de Fromentel C; Merle P
    J Hepatol; 2013 Nov; 59(5):1107-17. PubMed ID: 23835194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of Wnt/β-catenin signaling pathway in promoting tumorigenesis of hepatocellular carcinoma].
    Xie L; Jiang H; Wu F
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jun; 34(6):913-7. PubMed ID: 24968856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wnt/Frizzled signaling in hepatocellular carcinoma.
    Lee HC; Kim M; Wands JR
    Front Biosci; 2006 May; 11():1901-15. PubMed ID: 16368566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.
    Ma L; Wang X; Jia T; Wei W; Chua MS; So S
    Oncotarget; 2015 Sep; 6(28):25390-401. PubMed ID: 26246473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Wnt/β-catenin pathway as a therapeutic target in human hepatocellular carcinoma.
    Dahmani R; Just PA; Perret C
    Clin Res Hepatol Gastroenterol; 2011 Nov; 35(11):709-13. PubMed ID: 21778132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Wnt/β-catenin pathway in hepatocellular carcinoma treatment.
    Vilchez V; Turcios L; Marti F; Gedaly R
    World J Gastroenterol; 2016 Jan; 22(2):823-32. PubMed ID: 26811628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant regulation of Wnt signaling in hepatocellular carcinoma.
    Liu LJ; Xie SX; Chen YT; Xue JL; Zhang CJ; Zhu F
    World J Gastroenterol; 2016 Sep; 22(33):7486-99. PubMed ID: 27672271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of miR-432 activates Wnt/β-catenin signaling and promotes human hepatocellular carcinoma proliferation.
    Jiang N; Chen WJ; Zhang JW; Xu C; Zeng XC; Zhang T; Li Y; Wang GY
    Oncotarget; 2015 Apr; 6(10):7866-79. PubMed ID: 25797263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulation of Wnt/β-catenin signaling by protein kinases in hepatocellular carcinoma and its therapeutic application.
    Li Q; Sun M; Wang M; Feng M; Yang F; Li L; Zhao J; Chang C; Dong H; Xie T; Chen J
    Cancer Sci; 2021 May; 112(5):1695-1706. PubMed ID: 33605517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic alterations of Wnt signaling pathway-associated genes in hepatocellular carcinoma.
    Kim YD; Park CH; Kim HS; Choi SK; Rew JS; Kim DY; Koh YS; Jeung KW; Lee KH; Lee JS; Juhng SW; Lee JH
    J Gastroenterol Hepatol; 2008 Jan; 23(1):110-8. PubMed ID: 18171349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of small molecule inhibitors of the Wnt/β-catenin signaling pathway by targeting β-catenin/Tcf4 interactions.
    Yan M; Li G; An J
    Exp Biol Med (Maywood); 2017 Jun; 242(11):1185-1197. PubMed ID: 28474989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatoprotective effect of hesperidin in hepatocellular carcinoma: Involvement of Wnt signaling pathways.
    Zaghloul RA; Elsherbiny NM; Kenawy HI; El-Karef A; Eissa LA; El-Shishtawy MM
    Life Sci; 2017 Sep; 185():114-125. PubMed ID: 28754618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Action and function of Wnt/β-catenin signaling in the progression from chronic hepatitis C to hepatocellular carcinoma.
    Wang W; Pan Q; Fuhler GM; Smits R; Peppelenbosch MP
    J Gastroenterol; 2017 Apr; 52(4):419-431. PubMed ID: 28035485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-negative feedback loop between Wnt-β-catenin signaling and HNF4α regulates epithelial-mesenchymal transition in hepatocellular carcinoma.
    Yang M; Li SN; Anjum KM; Gui LX; Zhu SS; Liu J; Chen JK; Liu QF; Ye GD; Wang WJ; Wu JF; Cai WY; Sun GB; Liu YJ; Liu RF; Zhang ZM; Li BA
    J Cell Sci; 2013 Dec; 126(Pt 24):5692-703. PubMed ID: 24101726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of miR-610 promotes proliferation and tumorigenicity and activates Wnt/β-catenin signaling in human hepatocellular carcinoma.
    Zeng XC; Liu FQ; Yan R; Yi HM; Zhang T; Wang GY; Li Y; Jiang N
    Mol Cancer; 2014 Dec; 13():261. PubMed ID: 25491321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WNT/β-catenin signaling in the development of liver cancers.
    He S; Tang S
    Biomed Pharmacother; 2020 Dec; 132():110851. PubMed ID: 33080466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Destruxin B inhibits hepatocellular carcinoma cell growth through modulation of the Wnt/β-catenin signaling pathway and epithelial-mesenchymal transition.
    Huynh TT; Rao YK; Lee WH; Chen HA; Le TD; Tzeng DT; Wang LS; Wu AT; Lin YF; Tzeng YM; Yeh CT
    Toxicol In Vitro; 2014 Jun; 28(4):552-61. PubMed ID: 24434019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.